[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Drug;Experimental Drug;Group A;Group B;Healthy subject in close contact with COVID-19 case(s);Patients with mild or asymptomatic COVID-19", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1090, "treatment_name": "Recombinant super-compound interferon (rsifn-co)", "treatment_type": "Interferons", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1090, "treatment_name": "Recombinant super-compound interferon (rsifn-co)", "treatment_type": "Interferons", "pharmacological_treatment": "Pharmacological treatment"}]